LifeTECH Invited to Address Third Annual Blood Safety & Screening Conference TORONTO, April 16 1997 - LifeTECH Corporation today announced that Dr. Peter Lea, LifeTECH's Director of Research & Development, has been invited to address the prestigious Third Annual Blood Safety & Screening Conference in Washington, D.C. from April 14-16, 1997. Dr. Lea's presentation, entitled "Controlled Oxidative Stress Inactivation of Virus", will describe the dramatic advances achieved by LifeTECH's Sterinetics(TM) System in the sterilization of blood and blood products. In making the announcement, Mr. Walter J. Dermott, President and CEO of LifeTECH, said "Over the last year, twelve abstracts describing LifeTECH's innovative research and development have been peer-reviewed and accepted by leading international scientific bodies. Dr. Lea's upcoming address to the Blood Safety and Screening Conference takes us to the next level in highlighting and validating our continuing scientific successes. Dr. Lea will describe the scientific basis for the Sterinetics System to become the only viable solution to the serious viral and bacterial contamination in the global blood supply. LifeTECH is now positioned to move centre stage in the global blood supply crisis and the $6-$10 billion worldwide marketplace for blood product sterilization" LifeTECH's Sterinetics System uses controlled oxidative stress to inactivate viruses and bacteria in blood components such as red blood cells, serum, plasma, platelets and intravenous products. LifeTECH research has confirmed inactivation of greater than 6 logs/ml of lipid coated viruses in Red Blood Cells and both lipid and non-lipid coated viruses in Intravenous Immunoglobulin. Specific viruses inactivated by the Sterinetics System include Simian Immunodeficiency Virus, which is virtually identical to the Human Immunodeficiency Virus, Bovine Viral Diarrhea Virus, which models the human Hepatitis C virus, Infectious Bovine Rhinotracheitis (IBR) which is a large herpes virus, and the much smaller Adenovirus, which is a respiratory virus found in both human and bovine species. The Blood Safety and Screening Conference was initially organized to respond to the threat of contamination of the global blood supply by viral and bacterial agents. Major topics at this year's conference include current infectious disease risks, the emergence of uncommon infectious diseases that pose a risk to the blood supply (Chagas and Malaria, parasitic diseases, Dengue Fever and Ebola), and new technologies to deal with these problems. Dr. Lea has been invited to be the first speaker in the "New Technologies" portion of the conference. The conference is attended by the world's leading researchers and scientists in blood safety, and by major international blood agencies, blood product manufacturers and governmental agencies.